Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Erasca securities between January 14, 2025, and April 26, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case.
Erasca Case Details
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, and failed to disclose material facts, including that:
- ERAS-0015’s preclinical data was based on improper comparisons to Revolution Medicines, Inc. (“RevMed”) and placed Erasca at risk of violating patent and trade secret protections; and
- based on the foregoing, defendants lacked a reasonable basis for their positive statements related to ERAS-0015.
What’s Next for Erasca Investors?
A class action lawsuit has already been filed. You may review a copy of the Complaint. You may also contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911. If you suffered a loss in Erasca you have until August 10, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff.
ERAS — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”